[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Iovance Biotherapeutics, Inc. Common Stock
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$IOVA - So apparently I know what I was talking about when I said the partnership with InspiroGene by McKesson is a game changer. XX years of pharmaceutical experience 🐉. Thats what you get from me. Free"
X Link @BIOTECHSCANNER 2025-10-15T14:20Z 7502 followers, 2323 engagements
"$IOVA - The company plans to release interim data on: X. Second Line NSCLC - If data is positive then they will wait for phase X to end and then apply for accelerated approval. Because this phase X is a pivotal trial. The company is using the same process as second line metastatic melanoma. The frontline NSCLC in combination with Pembrolizumab will have a dual purpose just like TILVANCE XXX that is to serve as a confirmatory for full second line NSCLC and accelerated frontline approval as well. A lot of attention is paid toward this data release because the NSCLC market is more than 6x of"
X Link @BIOTECHSCANNER 2025-10-15T13:42Z 7502 followers, 2276 engagements
"$IOVA IN JULY WAS A BIG MONEY INFLOW. @kainvests @BIOTECHSCANNER"
X Link @GhoutaNews 2025-10-15T08:59Z 2269 followers, 1042 engagements
"$IOVA The irony This company's never been more promising than it is right now. Most of the market's just lost interest perhaps bored as well as burned by the story. Just don't get lured into that same mindset. Sooner or later (and for better or worse) a stock reflects its company's value. @BIOTECHSCANNER"
X Link @GhoutaNews 2025-10-15T07:11Z 2269 followers, 1064 engagements